Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation

Genes and Development

Volumn 22, Issue 8, 2008, Pages 998-1010

  Puto, Lorena A ^a   Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

Daxx; DNA methylation; DNMT1; Epigenetics; RelB; Transcription

Indexed keywords

DAXX PROTEIN; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; MESSENGER RNA; PROTEIN; TRANSCRIPTION FACTOR RELB;

ANIMAL CELL; ARTICLE; BIRC3 GENE; C FLIP GENE; CONTROLLED STUDY; DAPK1 GENE; DAPK3 GENE; DNA METHYLATION; EMBRYO; EPIGENETICS; GENE REPRESSION; GENE SILENCING; GENE TARGETING; GENOME; HUMAN; HUMAN CELL; MOUSE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; DNA; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; TRANSCRIPTION FACTOR RELB; TRANSFECTION;

EID: 42149185026     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1632208     Document Type: Article

References (58)

1. Alcamo, E., Hacohen, N., Schulte, L.C., Rennert, P.D., Hynes, R.O., and Baltimore, D. 2002. Requirement for the NF-κB family member RelA in the development of secondary lymphoid organs. J. Exp. Med. 195: 233-244.
2. Baylin, S.B. 2005. DNA methylation and gene silencing in cancer. Nat. Clin. Pract. Oncol. 2 (Suppl. 1): S4-S11. doi:10.1038/ncponc0354.
3. Baylin, S.B. and Ohm, J.E. 2006. Epigenetic gene silencing in cancer - A mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer 6: 107-116.
4. Bialik, S. and Kimchi, A. 2006. The death-associated protein kinases: Structure, function, and beyond. Annu. Rev. Biochem. 75: 189-210.
5. Boehrer, S., Nowak, D., Hochmuth, S., Kim, S.Z., Trepohl, B., Afkir, A., Hoelzer, D., Mitrou, P.S., Weidmann, E., and Chow, K.U. 2005. Daxx overexpression in T-lymphoblastic Jurkat cells enhances caspase-dependent death receptor- and drug-induced apoptosis in distinct ways. Cell. Signal. 17: 581-595.
6. Boellmann, F., Guettouche, T., Guo, Y., Fenna, M., Mnayer, L., and Voellmy, R. 2004. DAXX interacts with heat shock factor 1 during stress activation and enhances its transcriptional activity. Proc. Natl. Acad. Sci. 101: 4100-4105.
7. Bonizzi, G. and Karin, M. 2004. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25: 280-288.
8. Bours, V., Azarenko, V., Dejardin, E., and Siebenlist, U. 1994. Human RelB (I-Rel) functions as a κB site-dependent transactivating member of the family of Rel-related proteins. Oncogene 9: 1699-1702.
9. Brenner, C., Deplus, R., Didelot, C., Loriot, A., Viré, E., De Smet, C., Gutierrez, A., Danovi, D., Bernard, D., Boon, T., et al. 2005. Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J. 24: 336-346.
10. Burkly, L., Hession, C., Ogata, L., Reilly, C., Marconi, L.A., Olson, D., Tizard, R., Cate, R., and Lo, D. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373: 531-536.
11. Cameron, E.E., Bachman, K.E., Myohanen, S., Herman, J.G., and Baylin, S.B. 1999. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet. 21: 103-107.
12. Campbell, K.J., Rocha, S., and Perkins, N.D. 2004. Active repression of antiapoptotic gene expression by RelA(p65) NF-κB. Mol. Cell 13: 853-865.
13. Carvin, C.D., Parr, R.D., and Kladde, M.P. 2003. Site-selective in vivo targeting of cytosine-5 DNA methylation by zincfinger proteins. Nucleic Acids Res. 31: 6493-6501.
14. Chen, L.Y. and Chen, J.D. 2003. Daxx silencing sensitizes cells to multiple apoptotic pathways. Mol. Cell. Biol. 23: 7108-7121.
15. Croxton, R., Puto, L.A., de Belle, I., Thomas, M., Torii, S., Hanaii, F., Cuddy, M., and Reed, J.C. 2006. Daxx represses expression of a subset of antiapoptotic genes regulated by nuclear factor-κB. Cancer Res. 66: 9026-9035.
16. D'Alessio, A.C. and Szyf, M. 2006. Epigenetic tete-a-tete: The bilateral relationship between chromatin modifications and DNA methylation. Biochem. Cell Biol. 84: 463-476.
17. Di Croce, L., Raker, V.A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Lo Coco, F., Kouzarides, T., Nervi, C., et al. 2002. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295: 1079-1082.
18. Dong, C. and Goldschmidt-Clermont, P.J. 2002. E2F1: A magic bullet for atherosclerosis? Circulation 106: 2640-2641.
19. Ecsedy, J.A., Michaelson, J.S., and Leder, P. 2003. Homeodomain- interacting protein kinase 1 modulates Daxx localization, phosphorylation, and transcriptional activity. Mol. Cell. Biol. 23: 950-960.
20. Emelyanov, A.V., Kovac, C.R., Sepulveda, M.A., and Birshtein, B.K. 2002. The interaction of Pax5 (BSAP) with Daxx can result in transcriptional activation in B cells. J. Biol. Chem. 277: 11156-11164.
21. Fraga, M.F. and Esteller, M. 2007. Epigenetics and aging: The targets and the marks. Trends Genet. 23: 413-418.
22. Frigola, J., Song, J., Stirzaker, C., Hinshelwood, R.A., Peinado, M.A., and Clark, S.J. 2006. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat. Genet. 38: 540-549.
23. Fuks, F., Burgers, W.A., Godin, N., Kasai, M., and Kouzarides, T. 2001. Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J. 20: 2536-2544.
24. Gore, S.D. 2005. Combination therapy with DNA methyltransferase inhibitors in hematologic malignancies. Nat. Clin. Pract. Oncol. 2 (Suppl. 1): S30-S35. doi: 10.1038/ncponc0346.
25. Hinnis, A.R., Luckett, J.C., and Walker, R.A. 2007. Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients. Br. J. Cancer 96: 639-645.
26. Hoffmann, A. and Baltimore, D. 2006. Circuitry of nuclear factor κB signaling. Immunol. Rev. 210: 171-186.
27. Hollenbach, A.D., Sublett, J.E., McPherson, C.J., and Grosveld, G. 1999. The Pax3-FKHR oncoprotein is unresponsive to the pax3-associated repressor hDaxx. EMBO J. 18: 3702-3711.
28. Hollenbach, A.D., McPherson, C.J., Mientjes, E.J., Iyengar, R., and Grosveld, G. 2002. Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek. J. Cell Sci. 115: 3319-3330.
29. Hsieh, C.L. 1994. Dependence of transcriptional repression on CpG methylation density. Mol. Cell. Biol. 14: 5487-5494.
30. Jacque, E., Tchenio, T., Piton, G., Romeo, P.H., and Baud, V. 2005. RelA repression of RelB activity induces selective gene activation downstream of TNF receptors. Proc. Natl. Acad. Sci. 102: 14635-14640.
31. Kawai, T., Akira, S., and Reed, J.C. 2003. ZIP kinase triggers apoptosis from nuclear PML oncogenic domains (PODs). Mol. Cell. Biol. 23: 6174-6186.
32. Khelifi, A.F., D'Alcontres, M.S., and Salomoni, P. 2005. Daxx is required for stress-induced cell death and JNK activation. Cell Death Differ. 12: 724-733.
33. Kim, E.J., Park, J.S., and Um, S.J. 2003. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML. Nucleic Acids Res. 31: 5356-5367.
34. Li, R., Pei, H., Watson, D.K., and Papas, T.S. 2000. EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes. Oncogene 19: 745-753.
35. Lin, D.Y., Lai, M.Z., Ann, D.K., and Shih, H.M. 2003. Promyelocytic leukemia protein (PML) functions as a glucocorticoid receptor co-activator by sequestering Daxx to the PML oncogenic domains (PODs) to enhance its transactivation potential. J. Biol. Chem. 278: 15958-15965.
36. Lindsay, C.R., Scholz, A., Morozov, V.M., and Ishov, A.M. 2007. Daxx shortens mitotic arrest caused by paclitaxel. Cell Cycle 6: 1200-1204.
37. Marienfeld, R., May, M.J., Berberich, I., Serfling, E., Ghosh, S., and Neumann, M. 2003. RelB forms transcriptionally inactive complexes with RelA/p65. J. Biol. Chem. 278: 19852-19860.
38. Mathur, M., Tucker, P.W., and Samuels, H.H. 2001. PSF is a novel corepressor that mediates its effect through Sin3A and the DNA binding domain of nuclear hormone receptors. Mol. Cell. Biol. 21: 2298-2311.
39. Maul, G.G., Negorev, D., Bell, P., and Ishov, A.M. 2000. Review: Properties and assembly mechanisms of ND10, PML bodies, or PODs. J. Struct. Biol. 129: 278-287.
40. Michaelson, J.S. 2000. The Daxx enigma. Apoptosis 5: 217-220.
41. Michaelson, J.S., Bader, D., Kuo, F., Kozak, C., and Leder, P. 1999. Loss of Daxx, a promiscuously interactive protein, results in extensive apoptosis in early mouse development. Genes & Dev. 13: 1918-1923.
42. Muromoto, R., Sugiyama, K., Takachi, A., Imoto, S., Sato, N., Yamamoto, T., Oritani, K., Shimoda, K., and Matsuda, T. 2004. Physical and functional interactions between Daxx and DNA methyltransferase 1-associated protein, DMAP1. J. Immunol. 172: 2985-2993.
43. Perkins, N.D. and Gilmore, T.D. 2006. Good cop, bad cop: The different faces of NF-κB. Cell Death Differ. 13: 759-772.
44. Raval, A., Tanner, S.M., Byrd, J.C., Angerman, E.B., Perko, J.D., Chen, S.S., Hackanson, B., Grever, M.R., Lucas, D.M., Matkovic, J.J., et al. 2007. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 129: 879-890.
45. Robertson, K.D., Hayward, S.D., Ling, P.D., Samid, D., and Ambinder, R.F. 1995. Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: Evidence that demethylation at a single CpG site is crucial. Mol. Cell. Biol. 15: 6150-6159.
46. Ruben, S.M., Klement, J.F., Coleman, T.A., Maher, M., Chen, C.H., and Rosen, C.A. 1992. I-Rel: A novel rel-related protein that inhibits NF-κB transcriptional activity. Genes & Dev. 6: 745-760.
47. Ryseck, R.P., Bull, P., Takamiya, M., Bours, V., Siebenlist, U., Dobrzanski, P., and Bravo, R. 1992. RelB, a new Rel family transcription activator that can interact with p50-NF-κB. Mol. Cell. Biol. 12: 674-684.
48. Salomoni, P. and Khelifi, A.F. 2006. Daxx: Death or survival protein? Trends Cell Biol. 16: 97-104.
49. Schneider, G., Saur, D., Siveke, J.T., Fritsch, R., Greten, F.R., and Schmid, R.M. 2006. IKKα controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression. EMBO J. 25: 3801-3812.
50. Shamay, M., Krithivas, A., Zhang, J., and Hayward, S.D. 2006. Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA. Proc. Natl. Acad. Sci. 103: 14554-14559.
51. Takahashi, Y., Lallemand-Breitenbach, V., Zhu, J., and De The, H. 2004. PML nuclear bodies and apoptosis. Oncogene 23: 2819-2824.
52. Tang, J., Wu, S., Liu, H., Stratt, R., Barak, O.G., Shiekhattar, R., Picketts, D.J., and Yang, X. 2004. A novel transcription regulatory complex containing Daxx and the ATR-X syndrome protein. J. Biol. Chem. 279: 20369-20377.
53. Torii, S., Egan, D.A., Evans, R.A., and Reed, J.C. 1999. Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs). EMBO J. 18: 6037-6049.
54. Tzeng, S.L., Cheng, Y.W., Li, C.H., Lin, Y.S., Hsu, H.C., and Kang, J.J. 2006. Physiological and functional interactions between TCF4 and Daxx in colon cancer cells. J. Biol. Chem. 281: 15405-15411.
55. Valnet-Rabier, M.B., Challier, B., Thiebault, S., Angonin, R., Margueritte, G., Mougin, C., Kantelip, B., Deconinck, E., Cahn, J.-Y., Fest, T. 2005. c-Flip protein expression in Burkitt's lymphomas is associated with a poor clinical outcome. Br. J. Haematol. 128: 767-773.
56. Varfolomeev, E., Blankenship, J.W., Wayson, S.M., Fedorova, A.V., Kayagaki, N., Garg, P., Zobel, K., Dynek, J.N., Elliott, L.O., Wallweber, H.J., et al. 2007. IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis. Cell 131: 669-681.
57. Viiri, K.M., Korkeamäki, H., Kukkonen, M.K., Nieminen, L.K., Lindfors, K., Peterson, P., Mäki, M., Kainulainen, H., and Lohi, O. 2006. SAP30L interacts with members of the Sin3A corepressor complex and targets Sin3A to the nucleolus. Nucleic Acids Res. 34: 3288-3298.
58. Xue, Y., Gibbons, R., Yan, Z., Yang, D., McDowell, T.L., Sechi, S., Qin, J., Zhou, S., Higgs, D., and Wang, W. 2003. The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proc. Natl. Acad. Sci. 100: 10635-10640.